ApoB/ApoA-I Ratio

Cardiovascular

Advanced Lipid Markers

ratio

The ApoB/ApoA-I ratio compares the number of atherogenic particles (LDL and VLDL, which carry ApoB) against protective HDL particles (which carry ApoA-I), distilling the balance of harmful to protective lipoproteins into a single figure. A preventive practice tracks it because this balance often predicts cardiovascular risk more powerfully than any individual cholesterol value.

What It Measures

Ratio of atherogenic to protective particles; may be the single best lipid risk predictor

Optimal vs. Lab Range

Longevity Optimal

<0.6 (low risk)

Target range for optimal health and longevity based on research.

Standard Lab

N/A (calculated)

Population-based reference range from standard labs.

Why It Matters

The ApoB/ApoA-I ratio captures the balance between atherogenic (LDL/VLDL) and protective (HDL) particles. It outperforms standard cholesterol panels for predicting myocardial infarction and is one of the strongest single lipid markers of cardiovascular risk.

When Low

Generally favorable when low

When High

Strong predictor of myocardial infarction, stroke; captures both attack and defense in one number

How to Optimize

Lower ApoB through reduced saturated fat intake, increased soluble fiber (oats, legumes, psyllium), weight loss, and statins or PCSK9 inhibitors when indicated. Raise ApoA-I via aerobic exercise, omega-3s, smoking cessation, and improved metabolic health.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Address both ApoB (lower) and ApoA-I (raise)

Linked Compounds & Supplements

Omega-3

Berberine

Niacin

Plant sterols

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

ratio

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift ApoB/ApoA-I Ratio.
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.